Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05876273 · ClinicalTrials.gov registry record · NA
Neural-net Artificial Pancreas (NAP)
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT05876273: Completed NA study, sponsored by University of Virginia.
NCT05876273 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05876273, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study is intended to assess a Neural-net Artificial Pancreas (NAP) implementation of an established AP controller - the University of Virginia Model Predictive Control Algorithm (UMPC). The health outcomes achieved on NAP will be compared to the health outcomes achieved on UMPC in a randomized crossover design. The investigators will consent up to 20 participants, ages ≥18.0, with a goal of completing 15 participants.
Primary Outcome
The primary outcome is percent of time in 70 to 180 mg/dL range on NAP vs UMPC.
Interventions
- DEVICE Neural-net Artificial Pancreas
- DEVICE University of Virginia Model Predictive Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-05-30 |
| Est. Completion | 2023-09-10 |
| Phase | NA |
What the finished NCT05876273 record still lists
NCT05876273 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Neural-net Artificial Pancreas is the first listed.
NCT05876273 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05876273 about?
NCT05876273 is a clinical study titled "Neural-net Artificial Pancreas (NAP)". This study is intended to assess a Neural-net Artificial Pancreas (NAP) implementation of an established AP controller - the University of Virginia Model Predictive Control Algorithm (UMPC). The health outcomes achieved on NAP will be compared to the health outcomes achieved on UMPC in a randomized ...
What is the current status of trial NCT05876273?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2023-05-30. Estimated completion is 2023-09-10.
What interventions are being tested in trial NCT05876273?
The interventions under investigation include: Neural-net Artificial Pancreas (DEVICE), University of Virginia Model Predictive Control (DEVICE).
Who is sponsoring clinical trial NCT05876273?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05876273's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI